FDMT icon

4D Molecular Therapeutics

77 hedge funds and large institutions have $541M invested in 4D Molecular Therapeutics in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 7 reducing their positions, and 8 closing their positions.

Holders
77
Holders Change
+14
Holders Change %
+22.22%
% of All Funds
1.19%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
22
Increased
43
Reduced
7
Closed
8
Calls
$9K
Puts
$495K
Net Calls
-$486K
Net Calls Change
-$484K
Name Holding Trade Value Shares
Change
Shares
Change %
NFSG
76
Newbridge Financial Services Group
Florida
$1K
Manulife (Manufacturers Life Insurance)
77
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$304 +$58 +2,656 +24%
Alkeon Capital Management
78
Alkeon Capital Management
New York
-$16.2M -602,225 Closed
PA
79
Perceptive Advisors
New York
-$10.1M -375,256 Closed
CC
80
Centiva Capital
New York
-$7.22M -358,863 Closed
Millennium Management
81
Millennium Management
New York
-$4.19M -155,258 Closed
SCM
82
Soleus Capital Management
Connecticut
-$3.26M -120,900 Closed
MFS
83
Mirabella Financial Services
United Kingdom
-$380K -14,080 Closed
Rockefeller Capital Management
84
Rockefeller Capital Management
New York
-$28K -1,070 Closed
EWA
85
Evolution Wealth Advisors
Florida
-$4K -145 Closed